Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016 (2016), Article ID 8961709, 7 pages
http://dx.doi.org/10.1155/2016/8961709
Research Article

Balneotherapy Together with a Psychoeducation Program for Benzodiazepine Withdrawal: A Feasibility Study

1Service Hospitalo Universitaire de Santé Mentale et de Thérapeutique, Université Paris Descartes, Centre Hospitalier Sainte Anne, Paris, France
2INSERM UMR 894, PRES Sorbonne Centre de Psychiatrie et Neurosciences, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
3Laboratoire de Psychopathologie et Processus de Santé (EA 4057), Institut de Psychologie, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
4Institute of Public Health, Epidemiology and Development “ISPED”, Bordeaux University, Bordeaux, France
5Le Manoir Clinic, 09400 Ussat les Bains, France
6APHP, Département de Psychiatrie et de Médecine Addictologique, Hôpital Fernand Vidal, Paris, France
7Saujon Clinic, BP 30, 17600 Saujon, France

Received 23 July 2016; Accepted 11 October 2016

Academic Editor: Giuseppe Morgia

Copyright © 2016 P. De Maricourt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Billioti de Gage, Y. Moride, T. Ducruet et al., “Benzodiazepine use and risk of Alzheimer's disease: case-control study,” British Medical Journal, vol. 349, Article ID g5205, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. C. I. Neutel, “The epidemiology of long-term benzodiazepine use,” International Review of Psychiatry, vol. 17, no. 3, pp. 189–197, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. S.-Y. Fang, C.-Y. Chen, I.-S. Chang, E. C.-H. Wu, C.-M. Chang, and K.-M. Lin, “Predictors of the incidence and discontinuation of long-term use of benzodiazepines: a population-based study,” Drug and Alcohol Dependence, vol. 104, no. 1-2, pp. 140–146, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Alonso, M. C. Angermeyer, S. Bernert et al., “Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project,” Acta Psychiatrica Scandinavica, Supplement, vol. 109, no. 420, pp. 55–64, 2004. View at Google Scholar · View at Scopus
  5. I. Gasquet, L. Nègre-Pagès, A. Fourrier et al., “Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD/MHEDEA 2000 epidemiological study,” Encephale, vol. 31, no. 2, pp. 195–206, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. R. C. O. Voshaar, J. E. Couvée, A. J. L. M. van Balkom, P. G. H. Mulder, and F. G. Zitman, “Strategies for discontinuing long-term benzodiazepine use: meta-analysis,” British Journal of Psychiatry, vol. 189, pp. 213–220, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. O. Dubois, R. Salamon, C. Germain et al., “Balneotherapy versus paroxetine in the treatment of generalized anxiety disorder,” Complementary Therapies in Medicine, vol. 18, no. 1, pp. 1–7, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Dubois, R. Salamon, C. Germain, C. Vaugeois, A. Galinowski, and J.-P. Olié, “Crenotherapy,” Encephale, vol. 34, no. 3, pp. 309–310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Blasche, V. Leibetseder, and W. Marktl, “Association of spa therapy with improvement of psychological symptoms of occupational burnout: a pilot study,” Forschende Komplementarmedizin, vol. 17, no. 3, pp. 132–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Toda, K. Morimoto, S. Nagasawa, and K. Kitamura, “Change in salivary physiological stress markers by spa bathing,” Biomedical Research, vol. 27, no. 1, p. 114, 2006. View at Google Scholar
  11. D. Marazziti, S. Baroni, G. Giannaccini et al., “Thermal balneotherapy induces changes of the platelet serotonin transporter in healthy subjects,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 31, no. 7, pp. 1436–1439, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Yamamoto, Y. Aso, S. Nagata, K. Kasugai, and S. Maeda, “Autonomic, neuro-immunological and psychological responses to wrapped warm footbaths—a pilot study,” Complementary Therapies in Clinical Practice, vol. 14, no. 3, pp. 195–203, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. U. Lange, U. Müller-Ladner, and K. L. Schmidt, “Balneotherapy in rheumatic diseases-an overview of novel and known aspects,” Rheumatology International, vol. 26, no. 6, pp. 497–499, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Bellometti and L. Galzigna, “Function of the hypothalamic adrenal axis in patients with fibromyalgia syndrome undergoing mud-pack treatment,” International Journal of Clinical Pharmacology Research, vol. 19, no. 1, pp. 27–33, 1999. View at Google Scholar · View at Scopus
  15. E. Schauer, F. Trautinger, A. Köck et al., “Proopiomelanocortin-derived peptides are synthesized and released by human keratinocytes,” Journal of Clinical Investigation, vol. 93, no. 5, pp. 2258–2262, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Dönmez, M. Z. Karagülle, N. Tercan et al., “SPA therapy in fibromyalgia: a randomised controlled clinic study,” Rheumatology International, vol. 26, no. 2, pp. 168–172, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. F. D. S. Tursi, C. V. W. Baes, F. R. D. B. Camacho, S. M. D. C. Tofoli, and M. F. Juruena, “Effectiveness of psychoeducation for depression: a systematic review,” Australian and New Zealand Journal of Psychiatry, vol. 47, no. 11, pp. 1019–1031, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Casañas, R. Catalán, J. L. del Val, J. Real, S. Valero, and M. Casas, “Effectiveness of a psycho-educational group program for major depression in primary care: a randomized controlled trial,” BMC Psychiatry, vol. 12, article 230, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. S. V. Parikh, A. Zaretsky, S. Beaulieu et al., “A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety Treatments (CANMAT) study,” Journal of Clinical Psychiatry, vol. 73, no. 6, pp. 803–810, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Eker and S. Harkin, “Effectiveness of six-week psychoeducation program on adherence of patients with bipolar affective disorder,” Journal of Affective Disorders, vol. 138, no. 3, pp. 409–416, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Xia, L. B. Merinder, and M. R. Belgamwar, “Psychoeducation for schizophrenia,” Cochrane Database of Systematic Reviews, no. 6, Article ID CD002831, 2011. View at Google Scholar · View at Scopus
  22. L. Dutra, G. Stathopoulou, S. L. Basden, T. M. Leyro, M. B. Powers, and M. W. Otto, “A meta-analytic review of psychosocial interventions for substance use disorders,” American Journal of Psychiatry, vol. 165, no. 2, pp. 179–187, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. D. A. Chavira and M. B. Stein, “Combined psychoeducation and treatment with selective serotonin reuptake inhibitors for youth with generalized social anxiety disorder,” Journal of Child and Adolescent Psychopharmacology, vol. 12, no. 1, pp. 47–54, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. P. N. Dannon, I. Iancu, and L. Grunhaus, “Psychoeducation in panic disorder patients: effect of a self-information booklet in a randomized, masked-rater study,” Depression and Anxiety, vol. 16, no. 2, pp. 71–76, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. G. M. Manzoni, F. Pagnini, G. Castelnuovo, and E. Molinari, “Relaxation training for anxiety: a ten-years systematic review with meta-analysis,” BMC Psychiatry, vol. 8, article 41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Bjelland, A. A. Dahl, T. T. Haug, and D. Neckelmann, “The validity of the hospital anxiety and depression scale: an updated literature review,” Journal of Psychosomatic Research, vol. 52, no. 2, pp. 69–77, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. A. T. Beck, C. H. Ward, M. Mendelson, J. Mock, and J. Erbaugh, “An inventory for measuring depression,” Archives of General Psychiatry, vol. 4, pp. 561–571, 1961. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Pelissolo and W. J. Naja, “Evaluation de la dépendance aux BZD à l'aide d’une échelle cognitive,” Synapse, vol. 131, pp. 37–40, 1996. View at Google Scholar
  29. W. D. Scholten, N. M. Batelaan, P. van Oppen, J. H. Smit, and A. J. L. M. Van Balkom, “Discontinuation of antidepressants in remitted anxiety disorder patients: the need for strategies to prevent relapse,” Psychotherapy and Psychosomatics, vol. 82, no. 6, pp. 399–400, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. A. W. Calkins, M. W. Otto, L. S. Cohen et al., “Psychosocial predictors of the onset of anxiety disorders in women: results from a prospective 3-year longitudinal study,” Journal of Anxiety Disorders, vol. 23, no. 8, pp. 1165–1169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. W. J. M. J. Gorgels, R. C. Oude Voshaar, A. J. J. Mol et al., “Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice: a prospective controlled intervention study,” Drug and Alcohol Dependence, vol. 78, no. 1, pp. 49–56, 2005. View at Publisher · View at Google Scholar · View at Scopus